ResearcherCurtin UniversityNo recent work listed
Alice Domenichini
Matched on OpenAlex author ID A5091190430. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 4, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2017: 1 paper · 2018: none · 2019: 4 papers · 2020: 1 paper · 2021: none · 2022: 1 paper
Papers 7
- Extracellular vesicles derived from pancreatic cancer cells are enriched in the growth factor Midkine. Co-author DOI 10.1016/j.jbior.2021.100857↗
- Antiplatelet Drug Ticagrelor Enhances Chemotherapeutic Efficacy by Targeting the Novel P2Y12-AKT Pathway in Pancreatic Cancer Cells. First author DOI 10.3390/cancers12010250↗
- Pancreatic cancer tumorspheres are cancer stem-like cells with increased chemoresistance and reduced metabolic potential. Co-author DOI 10.1016/j.jbior.2019.02.001↗
- ABCC3 is a novel target for the treatment of pancreatic cancer. Co-author DOI 10.1016/j.jbior.2019.04.004↗
- Pharmacological inhibition of ABCC3 slows tumour progression in animal models of pancreatic cancer. First author DOI 10.1186/s13046-019-1308-7↗
- Dual PDK1/Aurora Kinase A Inhibitors Reduce Pancreatic Cancer Cell Proliferation and Colony Formation. First author DOI 10.3390/cancers11111695↗
- Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies. First author DOI 10.3390/ijms18071338↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Marco Falasca · 7 shared papers, 2017–2022 · strength 0.86
- Paper Extracellular vesicles derived from pancreatic cancer cells are enriched in the growth factor Midkine. DOI 10.1016/j.jbior.2021.100857↗
- Paper Antiplatelet Drug Ticagrelor Enhances Chemotherapeutic Efficacy by Targeting the Novel P2Y12-AKT Pathway in Pancreatic … DOI 10.3390/cancers12010250↗
- Paper Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies. DOI 10.3390/ijms18071338↗
- Aleksandra Adamska · 4 shared papers, 2017–2019 · strength 0.40
- Paper Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies. DOI 10.3390/ijms18071338↗
- Paper Pancreatic cancer tumorspheres are cancer stem-like cells with increased chemoresistance and reduced metabolic potentia… DOI 10.1016/j.jbior.2019.02.001↗
- Paper ABCC3 is a novel target for the treatment of pancreatic cancer. DOI 10.1016/j.jbior.2019.04.004↗
- Ilaria Casari · 2 shared papers, 2019–2022 · strength 0.33
- Aikaterini Emmanouilidi · 1 shared paper, 2022 · strength 0.22
- Vincenzo De Laurenzi · 2 shared papers, 2019 · strength 0.17
- Verena Damiani · 2 shared papers, 2019 · strength 0.17
- Norbaini Binti Abdol Razak · 1 shared paper, 2020 · strength 0.13
- Omar Elaskalani · 1 shared paper, 2020 · strength 0.13
- Pat Metharom · 1 shared paper, 2020 · strength 0.13
- Silvano Paternoster · 1 shared paper, 2019 · strength 0.11
- Riccardo Ferro · 1 shared paper, 2019 · strength 0.09
- Yulia Y. Maxuitenko · 1 shared paper, 2019 · strength 0.08
- Adam B. Keeton · 1 shared paper, 2019 · strength 0.08
- Pierluigi Di Sebastiano · 1 shared paper, 2019 · strength 0.08
- Gary Anthony Piazza · 1 shared paper, 2019 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.